AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12089124
Drug: Small Volume
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small Volume Nebuliser (SVN) (0.15 mg/kg)
Trial: 7497601
Drug: Carboplatin 42
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin 42 mg/m2 per day
Trial: 7497601
Drug: Carboplatin 35
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin 35 mg/m2 per day
Trial: 2841905
Drug: Carboplatin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboplatin (all doses)
Trial: 1645990
Drug: Anesthetic solutions
RxNorm normalized name: Gelato Anesthetic
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anesthetic solutions with added sodium bicarbonate
Trial: 1645990
Drug: Anesthetic solutions
RxNorm normalized name: Gelato Anesthetic
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anesthetic solutions without added sodium bicarbonate
Trial: 7021261
Drug: Flufenamic acid,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flufenamic acid, 100 mg, four times daily
Trial: 7021261
Drug: Paracetamol (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (up to 8 x 500 mg daily)
Trial: 30266874
Drug: Premature birth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Premature birth and not being cared by the biological parent
Trial: 27552352
Drug: High-Power Pain
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Power Pain Threshold (HPPT) ultrasound therapy
Trial: 17305652
Drug: Rosiglitazone (RSG)
DrugBank: Rosiglitazone (DB00412)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (RSG) 4 mg for 2 months and then 8 mg daily
Trial: 12029412
Drug: Slow endotracheal
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow endotracheal surfactant infusion
Trial: 12029412
Drug: Bolus administration
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus administration of surfactant
Trial: 9836210
Drug: Alfentanil 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 15 micrograms.kg‐1 followed by propofol 4 mg.kg‐1 with lignocaine 0.2 mg.kg‐1
Trial: 9836210
Drug: Remifentanil 1
RxNorm normalized name: remifentanil 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 1 microgram.kg‐1 followed by propofol 4 mg.kg‐1 with lignocaine 0.2 mg.kg‐1
Trial: 962994
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy and specific active immunotherapy (C+I)
Trial: 962994
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy (C)
Trial: 25448491
Drug: Conventional chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional chemotherapy plus lenalidomide (DLBCL-len)
Trial: 25448491
Drug: Conventional chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional chemotherapy (DLBCL-c)
Trial: 23883653
Drug: Renal denervation
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renal denervation on top of medical treatment
Trial: 8235664
Drug: 10MTX (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10MTX (10 mg/M2/wk)
Trial: 8235664
Drug: D-penicillamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-penicillamine (10 mg/kg/d)
Trial: 8235664
Drug: Hydroxychloroquine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine (6 mg/kg/d)
Trial: 8235664
Drug: Auranofin (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auranofin (0.15 to 0.20 mg/kg/d)
Trial: 8235664
Drug: 5MTX (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5MTX (5 mg/M2/wk)
Trial: 27803033
Drug: Bevacizumab, cisplatin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab, cisplatin, and paclitaxel (bevacizumab 15 mg/kg, cisplatin 50 mg/m2, paclitaxel 135 mg/m2 over 24 h or 175 mg/m2 over 3 h) administered every 3 weeks until disease progression or unacceptable toxicity.
Trial: 25475358
Drug: Phenylephrine 10
RxNorm normalized name: phenylephrine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine 10 mg with acetaminophen 1000 mg
Trial: 25475358
Drug: Phenylephrine 10
RxNorm normalized name: phenylephrine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine 10 mg with acetaminophen 500 mg
Trial: 25475358
Drug: Phenylephrine 5
RxNorm normalized name: phenylephrine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine 5 mg with acetaminophen 1000 mg
Trial: 24067392
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C tablet (50 mg)
Trial: 15575172
Drug: Topical calcipotriol
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical calcipotriol (50 microg/gm cream applied twice daily)
Trial: 15575172
Drug: Topical calcipotriol
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical calcipotriol (ointment)
Trial: 11052493
Drug: Nonsteroidal anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal anti-inflammatory drug, acetaminophen, or placebo for 2 weeks
Trial: 8554733
Drug: Pravastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (10 mg daily)
Trial: 3910706
Drug: Tiaprofenic acid
RxNorm normalized name: tiaprofenic acid
DrugBank: Tiaprofenic acid (DB01600)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiaprofenic acid (600 mg/day, 2 days before and 6 days after surgery)
Trial: 23020133
Drug: TRAP (thrombin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRAP (thrombin receptor activating peptide)
Trial: 20124218
Drug: Oral 6-thioguanine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 6-thioguanine (TG)
Trial: 20124218
Drug: Oral 6-mercaptopurine
RxNorm normalized name: 6-Mercaptopurine
DrugBank: Mercaptopurine (DB01033)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral 6-mercaptopurine (MP)
Trial: 12161768
Drug: Phentolamine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phentolamine (40 mg)
Trial: 12828169
Drug: Urapidil (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urapidil (25 mg intravenously)
Trial: 12828169
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg intravenously)
Trial: 8792442
Drug: 20mg low
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 20mg low dose aspirin
Trial: 8792442
Drug: 40mg low
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 40mg low dose aspirin
Trial: 8792442
Drug: 80mg low
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 80mg low dose aspirin
Trial: 1639047
Drug: 500 g
RxNorm normalized name: PRAZIQUANTEL 500 g in 500 g POWDER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 g salmon daily for 40 days
Trial: 6735964
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg daily tobramycin
Trial: 6735964
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg daily tobramycin
Trial: 6735964
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg daily tobramycin with 1000 mg neomycin
Trial: 31766627
Drug: Excessive body
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Excessive body weight >4000 g
Trial: 24527599
Drug: Neurac training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurac training combined with conventional treatments for 2 weeks
Trial: 24527599
Drug: Conventional treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatments (cervical traction, manual therapy, electrical therapy) for 2 weeks
Trial: 22569241
Drug: 130 mg
RxNorm normalized name: pectin 130 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 130 mg dehydroepiandrosterone (DHEA)
Trial: 20491724
Drug: Zonnic nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zonnic nicotine mouth spray (1 mg/spray)
Trial: 20491724
Drug: Zonnic nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zonnic nicotine lozenge (2.5 mg)
Trial: 20491724
Drug: Nicorette gum
RxNorm normalized name: nicotine Chewing Gum [Nicorette]
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicorette gum (4 mg)
Trial: 10354839
Drug: Minimized low-weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimized low-weight polypropylene mesh (26.8 g/m2, pore size 5 mm)
Trial: 10354839
Drug: Common heavy-weight
RxNorm normalized name: heavy mineral oil
DrugBank: Mineral oil (DB11057)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Common heavy-weight polypropylene mesh (90.2 g/m2, pore size 0.8 mm)
Trial: 7493424
Drug: Topical ouabain
RxNorm normalized name: ouabain
DrugBank: Ouabain (DB01092)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ouabain
Trial: 7493424
Drug: Topical amiloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical amiloride
Trial: 30915963
Drug: Touch-observation and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Touch-observation and task-based mirror therapy
Trial: 21223512
Drug: Bezafibrate (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bezafibrate (200 mg twice daily)
Trial: 21223512
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (1 g twice daily)
Trial: 15983318
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy (0.4 mg cerivastatin daily, later replaced by 20 mg simvastatin)
Trial: 12807387
Drug: Topiramate 600
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate 600 mg/day
Trial: 12807387
Drug: Topiramate 800
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate 800 mg/day
Trial: 8649569
Drug: Topiramate 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 1,000 mg/day
Trial: 26568588
Drug: Etanercept (ETN)
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept (ETN) 50 mg/week
Trial: 21176197
Drug: Intermittent preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent preventive treatment of malaria in infants (IPTi)
Trial: 15650664
Drug: 4-strand semitendinosus/gracilis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-strand semitendinosus/gracilis (ST/G) graft
Trial: 15650664
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (BPTB, ST, ST/G)
Trial: 12460326
Drug: Prednisolone 20
RxNorm normalized name: prednisolone 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 20 mg
Trial: 12460326
Drug: Prednisolone 40
RxNorm normalized name: prednisolone 40 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 40 mg
Trial: 22490579
Drug: rhNRG‐1 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhNRG‐1 (10 μg·kg‐1·d‐1, I.V.) for 10 days
Trial: 22490579
Drug: Sham-operated animals
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham-operated animals (no treatment)
Trial: 20649629
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (evening regimen)
Trial: 20649629
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (morning regimen)
Trial: 18616492
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg of melatonin 60 min before the procedure (group I)
Trial: 18616492
Drug: 0.5 mg.kg(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg.kg(‐1) melatonin 60 min before the procedure (group II)
Trial: 18616492
Drug: 0.75 mg.kg(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 mg.kg(‐1) midazolam 15 min before the procedure (group III)
Trial: 18616492
Drug: 3 ml
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ml of 0.09 NaCl 15 min (group IV)
Trial: 18616492
Drug: 3 ml
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ml of 0.09 NaCl 60 min (group IV)
Trial: 16554449
Drug: Etanercept (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept (10 mg, 25 mg, 50 mg)
Trial: 10553829
Drug: 0.3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg rapacuronium
Trial: 10553829
Drug: 0.6 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg/kg rapacuronium
Trial: 10553829
Drug: 0.9 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9 mg/kg rapacuronium
Trial: 8723577
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa 50 to 150 IU/kg SC plus i.v. iron twice weekly for 3 weeks
Trial: 1929509
Drug: Ibuprofen 0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 0.625 mg/kg
Trial: 1929509
Drug: Ibuprofen 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 1.25 mg/kg
Trial: 1929509
Drug: Ibuprofen 2.5
RxNorm normalized name: hydrocodone-ibuprofen 2.5 mg-200 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 2.5 mg/kg
Trial: 6135300
Drug: Naloxone (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (400 micrograms, 1 ml injection)
Trial: 6135300
Drug: Sodium Chloride
RxNorm normalized name: Sodium Chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium Chloride (0.9%, 1 ml injection)
Trial: 29159694
Drug: SDPM-CIP tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SDPM-CIP tablets
Trial: 29159694
Drug: CIPRO XR®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIPRO XR® bilayer tablets
Trial: 28207527
Drug: Zhibitai 480
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zhibitai 480 mg + atorvastatin 10 mg (ZA10 group)
Trial: 28207527
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg (A40 group)
Trial: 28207527
Drug: Atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 20 mg (A20 group)
Trial: 26180243
Drug: 6 g
RxNorm normalized name: FAPi-46 GA-68
DrugBank: FAPi-46 GA-68 (DB18827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g α-GOSs/d
Trial: 26180243
Drug: 12 g
RxNorm normalized name: PEG-12 GLYCERYL LAURATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 g α-GOSs/d
Trial: 26180243
Drug: 18 g
RxNorm normalized name: flotufolastat F 18 gallium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18 g α-GOSs/d
Trial: 26180243
Drug: Control (glucose
RxNorm normalized name: INFINITY CONTROL (GLUCOSE) NORMAL CONTROL SOLN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (glucose syrup)
Trial: 18322873
Drug: Nonsurgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsurgical treatment (endoluminal stenting)
Trial: 17725149
Drug: Ginger (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger (0.5 gram per capsule, 2 capsules taken one hour before surgery)
Trial: 10739506
Drug: Intranasal 17beta-estradiol
RxNorm normalized name: Estradiol-17beta
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal 17beta-estradiol (300 microg/d)
Trial: 10739506
Drug: Oral micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral micronized estradiol (2 mg/d)
Trial: 15794392
Drug: Self-Injection Anxiety
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-Injection Anxiety Therapy (SIAT)
Trial: 10036345
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) 1 mg (4 puffs) plus 2.5 mg nebulized salbutamol
Trial: 10036345
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus 2.5 mg nebulized salbutamol
Trial: 1778084
Drug: Ser-316 suppository
RxNorm normalized name: Ser
DrugBank: Serine (DB00133)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ser-316 suppository (3 suppositories/week for 6 months)
Trial: 371339
Drug: Levomepromazine, 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levomepromazine, 12.5 mg
Trial: 371339
Drug: Pethidine, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pethidine, 50 mg
Trial: 31679359
Drug: Fish +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish + Walnut diet (150 g fish and 9 walnuts/week)
Trial: 31679359
Drug: Fish diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish diet (300 g/week)
Trial: 27913695
Drug: CoQ 2,400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CoQ 2,400 mg/d
Trial: 26291797
Drug: CC plus
RxNorm normalized name: STATLOCK PICC PLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC plus NAC
Trial: 10352387
Drug: CC only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC only
Trial: 26291797
Drug: CC plus
RxNorm normalized name: STATLOCK PICC PLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC plus metformin
Trial: 17577032
Drug: Lomeguatrib (LM)
RxNorm normalized name: LM-030
DrugBank: LM-030 (DB18283)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lomeguatrib (LM) and Temozolomide (TMZ) at doses of 40 to 80 mg LM and 125 mg/m2 TMZ
Trial: 17577032
Drug: Temozolomide (TMZ)
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Temozolomide (TMZ) at a dose of 200 mg/m2
Trial: 11450069
Drug: Neuromuscular Blocking
RxNorm normalized name: Neuromuscular blocking agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuromuscular Blocking Agents (NBA)
Trial: 11450069
Drug: No Neuromuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Neuromuscular Blocking Agents (Control)
Trial: 9349334
Drug: Topical doxepin
RxNorm normalized name: doxepin Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical doxepin
Trial: 7909999
Drug: Oral terfenadine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral terfenadine
Trial: 8451599
Drug: Glucagon infusion
RxNorm normalized name: Glucagon
DrugBank: Glucagon (DB00040)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Glucagon infusion (5 ng kg‐1 min‐1)
Trial: 29144812
Drug: Intensive medical
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive medical therapy (IMT; n = 25)
Trial: 24571582
Drug: 3 months
RxNorm normalized name: TABLET, DOSE PACK, 3 MONTHS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 months of leuprolide acetate injections (Group A)
Trial: 24571582
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months of leuprolide acetate injections (Group B)
Trial: 19462276
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (FNA) 3 mg IV weekly
Trial: 19462276
Drug: Vitamin B12
RxNorm normalized name: Vitamin B12
DrugBank: Cyanocobalamin Co-57 (DB09385)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin B12 1 mg IV weekly
Trial: 19462276
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of folinic acid and vitamin B12 IV weekly
Trial: 7707099
Drug: Morphine hydrochloride
RxNorm normalized name: Morphine hydrochloride
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine hydrochloride 10 mg orally
Trial: 7707099
Drug: Morphine hydrochloride
RxNorm normalized name: Morphine hydrochloride
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine hydrochloride 10 mg rectally
Trial: 780062
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 (oral solution)
Trial: 780062
Drug: Oxytocin (buccal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin (buccal tablets)
Trial: 30277102
Drug: Obinutuzumab plus
RxNorm normalized name: Obinutuzumab
DrugBank: Obinutuzumab (DB08935)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Obinutuzumab plus CHOP (G-CHOP)
Trial: 30277102
Drug: Shorter duration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shorter duration of infusion (SDI) of obinutuzumab
Trial: 21121874
Drug: omalizumab (75-375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: omalizumab (75-375 mg sc, q2 or q4 wk)
Trial: 17491173
Drug: NOT Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NOT Plus (Web-based adjunct)